Last reviewed · How we verify
NCT04195737
Comparison of Coronally Advanced Root Coverage Procedure With Collagen Matrix and Connective Tissue Graft
NA trial testing Ossix volumax collagen matrix in Gingival Recession in 60 participants. Completed in 6 August 2021.
17 July 2021
Quick facts
| Lead sponsor | Krishnadevaraya College of Dental Sciences & Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 12 December 2019 |
| Primary completion | 17 July 2021 |
| Estimated completion | 6 August 2021 |
| Sites | 1 location across India |
Drugs / interventions tested
- Ossix volumax collagen matrix
- Connective Tissue Graft — full drug profile →
Conditions studied
- Gingival Recession — all drugs for Gingival Recession →
Sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Who can join
Adults 18 to 58, any sex, with Gingival Recession. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study is a human, prospective, randomised controlled clinical trial conducted to explore the outcome of a coronally advanced flap with ossix volumaxTM collagen matrix and connective tissue graft in the treatment of multiple adjacent gingival recession defects. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04195737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gingival Recession
Currently open trials in the same condition.
- NCT07513792 — The Impact of a 3D Imaging Tool on Reducing Gum Recession During Orthodontic Treatment With Aligners · NA · recruiting
- NCT07437417 — A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth · NA · recruiting
- NCT07158541 — Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible · NA · recruiting
- NCT07104019 — Biofiller and Gingival Phenotype Thickening · NA · recruiting
- NCT07291583 — Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession · NA · active not recruiting
Other Krishnadevaraya College of Dental Sciences & Hospital trials
Trials by the same sponsor.
- NCT06525285 — MCAF and EMD With and Without CTG Wall Technique for the Treatment of Class III and IV Gingival recessions-a Randomized · NA · recruiting
- NCT06541912 — Comparative Evaluation of Implant Stability, Soft & Hard Tissue Healing Around UV Activated vs Conventional Implants · NA · recruiting
- NCT06775392 — Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Sc · Phase 1 · completed
- NCT06060119 — Comparison of Microneedling and CTG for Gingival Augmentation- A RCT · Phase 2 · unknown
- NCT06522321 — Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone · Phase 2 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04195737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Krishnadevaraya College of Dental Sciences & Hospital
- Last refreshed: 27 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04195737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing